BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 33082446)

  • 21. The Various Roles of Fatty Acids.
    de Carvalho CCCR; Caramujo MJ
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30304860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and inhibitory activity of mechanism-based 4-coumaroyl-CoA ligase inhibitors.
    Watanabe B; Kirikae H; Koeduka T; Takeuchi Y; Asai T; Naito Y; Tokuoka H; Horoiwa S; Nakagawa Y; Shimizu BI; Mizutani M; Hiratake J
    Bioorg Med Chem; 2018 May; 26(9):2466-2474. PubMed ID: 29685682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous fatty acid metabolism in bacteria.
    Yao J; Rock CO
    Biochimie; 2017 Oct; 141():30-39. PubMed ID: 28668270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials.
    Morvan C; Halpern D; Kénanian G; Hays C; Anba-Mondoloni J; Brinster S; Kennedy S; Trieu-Cuot P; Poyart C; Lamberet G; Gloux K; Gruss A
    Nat Commun; 2016 Oct; 7():12944. PubMed ID: 27703138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria.
    Yao J; Bruhn DF; Frank MW; Lee RE; Rock CO
    J Biol Chem; 2016 Jan; 291(1):171-81. PubMed ID: 26567338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using modern tools to probe the structure-function relationship of fatty acid synthases.
    Finzel K; Lee DJ; Burkart MD
    Chembiochem; 2015 Mar; 16(4):528-547. PubMed ID: 25676190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Versatility of acyl-acyl carrier protein synthetases.
    Beld J; Finzel K; Burkart MD
    Chem Biol; 2014 Oct; 21(10):1293-1299. PubMed ID: 25308274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor.
    Schiebel J; Chang A; Shah S; Lu Y; Liu L; Pan P; Hirschbeck MW; Tareilus M; Eltschkner S; Yu W; Cummings JE; Knudson SE; Bommineni GR; Walker SG; Slayden RA; Sotriffer CA; Tonge PJ; Kisker C
    J Biol Chem; 2014 Jun; 289(23):15987-6005. PubMed ID: 24739388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.
    Wang Y; Ma S
    ChemMedChem; 2013 Oct; 8(10):1589-608. PubMed ID: 23894064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice.
    Lun S; Guo H; Adamson J; Cisar JS; Davis TD; Chavadi SS; Warren JD; Quadri LE; Tan DS; Bishai WR
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5138-40. PubMed ID: 23856770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
    Engelhart CA; Aldrich CC
    J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model.
    Banevicius MA; Kaplan N; Hafkin B; Nicolau DP
    J Chemother; 2013 Feb; 25(1):26-31. PubMed ID: 23433441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NIH Image to ImageJ: 25 years of image analysis.
    Schneider CA; Rasband WS; Eliceiri KW
    Nat Methods; 2012 Jul; 9(7):671-5. PubMed ID: 22930834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The acyl-acyl carrier protein synthetase from Synechocystis sp. PCC 6803 mediates fatty acid import.
    von Berlepsch S; Kunz HH; Brodesser S; Fink P; Marin K; Flügge UI; Gierth M
    Plant Physiol; 2012 Jun; 159(2):606-17. PubMed ID: 22535424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.
    Escaich S; Prouvensier L; Saccomani M; Durant L; Oxoby M; Gerusz V; Moreau F; Vongsouthi V; Maher K; Morrissey I; Soulama-Mouze C
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4692-7. PubMed ID: 21825292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current understanding of fatty acid biosynthesis and the acyl carrier protein.
    Chan DI; Vogel HJ
    Biochem J; 2010 Aug; 430(1):1-19. PubMed ID: 20662770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid activation in cyanobacteria mediated by acyl-acyl carrier protein synthetase enables fatty acid recycling.
    Kaczmarzyk D; Fulda M
    Plant Physiol; 2010 Mar; 152(3):1598-610. PubMed ID: 20061450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenylate-forming enzymes.
    Schmelz S; Naismith JH
    Curr Opin Struct Biol; 2009 Dec; 19(6):666-71. PubMed ID: 19836944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis.
    Arora P; Goyal A; Natarajan VT; Rajakumara E; Verma P; Gupta R; Yousuf M; Trivedi OA; Mohanty D; Tyagi A; Sankaranarayanan R; Gokhale RS
    Nat Chem Biol; 2009 Mar; 5(3):166-73. PubMed ID: 19182784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis.
    Lu X; Zhang H; Tonge PJ; Tan DS
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5963-6. PubMed ID: 18762421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.